Is a researcher at the BioTis unit (INSERM U1026, University of Bordeaux) and head of the "Cells and Quality" division within the ART BioPrint platform, where she contributes to the development and validation of advanced multicellular models for regenerative medicine and cancer research. With a background in immunology and tissue biology, she brings recognized expertise in the design, standardization, and quality assessment of bioprinted tissue constructs. Her work focuses on optimizing cellular viability, structural complexity, and functional relevance of 3D-printed models, ensuring their reproducibility and applicability in preclinical settings. She plays a central role in interdisciplinary research combining bioprinting techniques—including laser-assisted, inkjet, and microextrusion—with tailored bioinks and engineered cell systems. Through national training initiatives, she also coordinates hands-on workshops and educational programs to disseminate 3D bioprinting technologies across scientific and clinical communities. Her contributions support the emergence of human-relevant in vitro models that advance personalized medicine, reduce animal experimentation, and accelerate translational research in tissue engineering.
